# Michael Yellin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-yellin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,003 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 42 |
| i10-index | 80 |
| Last Known Institution | Celldex Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5066367673 |
| ORCID iD | https://orcid.org/0000-0002-1164-7614 |
| Works | 213 |

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Researcher university

- [Celldex Therapeutics (United States)](https://scholariq.org/institutions/celldex-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.